Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control
- PMID: 34093852
- PMCID: PMC8171103
- DOI: 10.7150/thno.60143
Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control
Abstract
Endothelial cells (ECs) constitute the innermost layer in all blood vessels to maintain the structural integrity and microcirculation function for coronary microvasculature. Impaired endothelial function is demonstrated in various cardiovascular diseases including myocardial infarction (MI), which is featured by reduced myocardial blood flow as a result of epicardial coronary obstruction, thrombogenesis, and inflammation. In this context, understanding the cellular and molecular mechanisms governing the function of coronary ECs is essential for the early diagnosis and optimal treatment of MI. Although ECs contain relatively fewer mitochondria compared with cardiomyocytes, they function as key sensors of environmental and cellular stress, in the regulation of EC viability, structural integrity and function. Mitochondrial quality control (MQC) machineries respond to a broad array of stress stimuli to regulate fission, fusion, mitophagy and biogenesis in mitochondria. Impaired MQC is a cardinal feature of EC injury and dysfunction. Hence, medications modulating MQC mechanisms are considered as promising novel therapeutic options in MI. Here in this review, we provide updated insights into the key role of MQC mechanisms in coronary ECs and microvascular dysfunction in MI. We also discussed the option of MQC as a novel therapeutic target to delay, reverse or repair coronary microvascular damage in MI. Contemporary available MQC-targeted therapies with potential clinical benefits to alleviate coronary microvascular injury during MI are also summarized.
Keywords: ECs; coronary microvasculature; mitochondrial quality control; myocardial infarction.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures





Similar articles
-
BuyangHuanwu Decoction alleviates Endothelial Cell Apoptosis and Coronary Microvascular Dysfunction via Regulation of the MAPKK4/p38 Signaling Axis.Int J Med Sci. 2024 Sep 23;21(13):2464-2479. doi: 10.7150/ijms.98183. eCollection 2024. Int J Med Sci. 2024. PMID: 39439466 Free PMC article.
-
Involvement of mitochondrial dynamics and mitophagy in diabetic endothelial dysfunction and cardiac microvascular injury.Arch Toxicol. 2023 Dec;97(12):3023-3035. doi: 10.1007/s00204-023-03599-w. Epub 2023 Sep 14. Arch Toxicol. 2023. PMID: 37707623 Review.
-
Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: New insights into the mechanisms and therapeutic potentials.Pharmacol Res. 2020 Jun;156:104771. doi: 10.1016/j.phrs.2020.104771. Epub 2020 Mar 28. Pharmacol Res. 2020. PMID: 32234339 Review.
-
Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury.Biomolecules. 2020 Jan 5;10(1):85. doi: 10.3390/biom10010085. Biomolecules. 2020. PMID: 31948043 Free PMC article. Review.
-
Mitochondrial quality control mechanisms as molecular targets in diabetic heart.Metabolism. 2022 Dec;137:155313. doi: 10.1016/j.metabol.2022.155313. Epub 2022 Sep 17. Metabolism. 2022. PMID: 36126721 Review.
Cited by
-
BuyangHuanwu Decoction alleviates Endothelial Cell Apoptosis and Coronary Microvascular Dysfunction via Regulation of the MAPKK4/p38 Signaling Axis.Int J Med Sci. 2024 Sep 23;21(13):2464-2479. doi: 10.7150/ijms.98183. eCollection 2024. Int J Med Sci. 2024. PMID: 39439466 Free PMC article.
-
Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?Antioxid Redox Signal. 2023 Mar;38(7-9):599-618. doi: 10.1089/ars.2022.0126. Epub 2022 Dec 28. Antioxid Redox Signal. 2023. PMID: 36053670 Free PMC article. Review.
-
Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality.Front Pharmacol. 2024 Aug 30;15:1422686. doi: 10.3389/fphar.2024.1422686. eCollection 2024. Front Pharmacol. 2024. PMID: 39281286 Free PMC article. Review.
-
Nuciferine improves cardiac function in mice subjected to myocardial ischemia/reperfusion injury by upregulating PPAR-γ.Heliyon. 2023 Feb 11;9(2):e13630. doi: 10.1016/j.heliyon.2023.e13630. eCollection 2023 Feb. Heliyon. 2023. PMID: 36865453 Free PMC article.
-
PM2.5 induces inflammatory responses via oxidative stress-mediated mitophagy in human bronchial epithelial cells.Toxicol Res (Camb). 2022 Jan 19;11(1):195-205. doi: 10.1093/toxres/tfac001. eCollection 2022 Feb. Toxicol Res (Camb). 2022. PMID: 35237424 Free PMC article.
References
-
- Bassenge E, Heusch G. Endothelial and neuro-humoral control of coronary blood flow in health and disease. Reviews of physiology, biochemistry and pharmacology. 1990;116:77–165. - PubMed
-
- Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17:773–89. - PubMed
-
- Bausch D, Fritz S, Bolm L, Wellner UF, Fernandez-Del-Castillo C, Warshaw AL. et al. Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer. Angiogenesis. 2020;23:479–92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical